“…The incidence of Acanthamoeba infection has increased annually, especially in contact lens wearers (Khan, 2006;Ibrahim et al, 2009;Nielsen et al, 2020;de Lacerda and Lira, 2021). Along with the reports on drug resistance (Iovieno et al, 2010;Huang et al, 2017) and the limited anti-Acanthamoeba drugs available (Lorenzo-Morales et al, 2015;Szentmáry et al, 2019), these attract the researcher's attention to focus on the identification of new medicinal plants for therapeutic purposes of Acanthamoeba infection and a compound with greater inhibitory activity and less toxicity is urgently needed (Niyyati et al, 2016;Mahboob et al, 2018;Sanguan et al, 2018;Kolören et al, 2019;Elsheikha et al, 2020). Besides, a treatment strategy of multidrug combination therapy may be needed for drug resistance cases (Tyers and Wright, 2019).…”